EUVIMEDEUVIMED entdecken
Leserbrief

Response to correspondence by Dr Aamar on ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update’

Josef S Smolen, Christopher J Edwards, Victoria Konzett, Faidra Laskou, Robert Landewe, Andreas Kerschbaumer

Annals of the Rheumatic Diseases · 2026-09 · 85 (9) · e100-e101

DOI: 10.1016/j.ard.2026.06.026 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Annals of the Rheumatic Diseases, 2026-09. Verfasst von Josef S Smolen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine 3,Medical University of Vienna, Austria. Electronic address: josef.smolen@meduniwien.ac.at. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: European League Against Rheumatism.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Medicine 3,Medical University of Vienna, Austria. Electronic address: josef.smolen@meduniwien.ac.at.
  • NIHR Southampton Clinical Research Facility,University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Division of Rheumatology, Department of Medicine 3,Medical University of Vienna, Austria.
  • MRC Lifecourse Epidemiology Centre, Southampton, UK.
  • Amsterdam University Medical Center, Amsterdam and Zuyderland MC, Heerlen, the Netherlands.

Förderung

  • European League Against Rheumatism

Zitieren

APA

Smolen, J. S., Edwards, C. J., Konzett, V., Laskou, F., Landewe, R., & Kerschbaumer, A. (2026). Response to correspondence by Dr Aamar on ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update’. Annals of the Rheumatic Diseases, 85(9), e100-e101. https://doi.org/10.1016/j.ard.2026.06.026

Vancouver

Smolen JS, Edwards CJ, Konzett V, Laskou F, Landewe R, Kerschbaumer A. Response to correspondence by Dr Aamar on ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update’. Annals of the Rheumatic Diseases. 2026;85(9):e100-e101. doi:10.1016/j.ard.2026.06.026

BibTeX
@article{Smolen2026,
  author = {Smolen, Josef S and Edwards, Christopher J and Konzett, Victoria and Laskou, Faidra and Landewe, Robert and Kerschbaumer, Andreas},
  title = {Response to correspondence by Dr Aamar on ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update’},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {9},
  pages = {e100--e101},
  doi = {10.1016/j.ard.2026.06.026}
}
Kostenlos starten →